| Name | Title | Contact Details |
|---|
Huntington Medical Research Insitutes is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Circle Health Services, now affiliated with The Centers for Families and Children, is a nonprofit Federally Qualified Health Center (FQHC) that provides high-quality health care and related services to individuals and families regardless of their ability to pay. The Circle Health Services community health center, located at 12201 Euclid Avenue, is a 34,000 sq. ft. facility equipped with 18 examination rooms, five dental chairs, multiple group and individual therapy rooms, and an in-house pharmaceutical dispensary. The health center offers Adult and Pediatric Primary Care, a Teen/Reproductive Health Clinic, Dental Services, Behavioral Health Clinic, HIV Services, Dental Services, and Project DAWN (Deaths Avoided with Naloxone). Circle Health also operates a mobile syringe exchange program. Today, through its affiliation with The Centers for Families and Children, Circle Health operates under a shared leadership structure, which allows the organizations integrate behind-the-scenes administrative and operational support work and provide employees of both organizations access to the same benefits and professional development. Together, the organizations serve nearly 30,000 people and have more than 600 employees.
Queens-Long Island Medical Group, P.C. is a Garden City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.